Thomas Henry

10.1k total citations · 1 hit paper
107 papers, 7.1k citations indexed

About

Thomas Henry is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Thomas Henry has authored 107 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 40 papers in Immunology and 19 papers in Infectious Diseases. Recurrent topics in Thomas Henry's work include Inflammasome and immune disorders (45 papers), interferon and immune responses (19 papers) and Immune Response and Inflammation (19 papers). Thomas Henry is often cited by papers focused on Inflammasome and immune disorders (45 papers), interferon and immune responses (19 papers) and Immune Response and Inflammation (19 papers). Thomas Henry collaborates with scholars based in France, United States and Canada. Thomas Henry's co-authors include Denise M. Monack, François Vandenesch, Yvan Jamilloux, David S. Weiss, Gérard Lina, Thierry Walzer, Jean‐Pierre Gorvel, Sébastien Viel, Alexandre Bélot and P. Sève and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas Henry

104 papers receiving 7.0k citations

Hit Papers

Should we stimulate or su... 2020 2026 2022 2024 2020 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas Henry 4.1k 3.0k 1.5k 769 641 107 7.1k
Yun‐Gi Kim 3.7k 0.9× 3.4k 1.2× 1.2k 0.8× 498 0.6× 717 1.1× 73 7.3k
Blaise Corthésy 3.3k 0.8× 3.2k 1.1× 1.5k 1.0× 635 0.8× 708 1.1× 124 8.4k
Emma Slack 3.3k 0.8× 3.5k 1.2× 1.8k 1.1× 528 0.7× 689 1.1× 70 8.0k
Sho Yamasaki 4.2k 1.0× 5.6k 1.9× 2.1k 1.4× 325 0.4× 681 1.1× 198 10.8k
Adam F. Cunningham 1.3k 0.3× 2.4k 0.8× 1.3k 0.8× 789 1.0× 662 1.0× 142 6.1k
Marcel R. de Zoete 3.0k 0.7× 2.2k 0.7× 930 0.6× 308 0.4× 556 0.9× 50 5.6k
Sidonia Fagarasan 4.0k 1.0× 8.2k 2.8× 1.4k 0.9× 347 0.5× 897 1.4× 64 12.4k
Suzan H. M. Rooijakkers 2.1k 0.5× 2.0k 0.7× 2.4k 1.5× 351 0.5× 347 0.5× 109 5.3k
Anja A. Kühl 2.4k 0.6× 3.6k 1.2× 1.4k 0.9× 215 0.3× 1.0k 1.6× 219 8.8k
Eva Medina 2.0k 0.5× 2.7k 0.9× 2.1k 1.4× 300 0.4× 407 0.6× 128 6.6k

Countries citing papers authored by Thomas Henry

Since Specialization
Citations

This map shows the geographic impact of Thomas Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Henry more than expected).

Fields of papers citing papers by Thomas Henry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Henry. The network helps show where Thomas Henry may publish in the future.

Co-authorship network of co-authors of Thomas Henry

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Henry. A scholar is included among the top collaborators of Thomas Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Henry. Thomas Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buyck, Julien M., Sandrine Marchand, M. Marcotte, et al.. (2024). (E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii. International Journal of Pharmaceutics. 667(Pt A). 124907–124907. 1 indexed citations
2.
Ragupathy, Subramanyam, et al.. (2024). Flower Species Ingredient Verification Using Orthogonal Molecular Methods. Foods. 13(12). 1862–1862. 4 indexed citations
4.
Magnotti, Flora, et al.. (2023). Phosphoprotein phosphatase activity positively regulates oligomeric pyrin to trigger inflammasome assembly in phagocytes. mBio. 14(5). e0206623–e0206623. 2 indexed citations
5.
Boisset, Sandrine, et al.. (2023). Pathogenicity and virulence of Francisella tularensis. Virulence. 14(1). 2274638–2274638. 15 indexed citations
6.
Henry, Thomas, et al.. (2023). Terrestrial lichen caribou forage transplant success: year 5 and 6 results. Restoration Ecology. 31(4). 3 indexed citations
7.
Benech, Nicolas, Nathalie Rolhion, Cyriane Oeuvray, et al.. (2023). Gut microbiota alterations are associated with phenotype and genotype in familial Mediterranean fever. Lara D. Veeken. 63(4). 1039–1048. 2 indexed citations
8.
Niu, Tingting, Danish Patoli, Marine Groslambert, et al.. (2021). NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly. Nature Communications. 12(1). 5862–5862. 81 indexed citations
9.
Fauter, Maxime, Sébastien Viel, Pierre Pradat, et al.. (2020). Low glycosylated ferritin is a sensitive biomarker of severe COVID-19. Cellular and Molecular Immunology. 17(11). 1183–1185. 8 indexed citations
10.
Magnotti, Flora, Purnima Gupta, Christa Flechtenmacher, et al.. (2020). The Inflammasome Adaptor ASC Delays UV-Induced Skin Tumorigenesis in Beta HPV38 E6 and E7 Transgenic Mice. Journal of Investigative Dermatology. 141(1). 236–238.e2. 1 indexed citations
11.
Tromp, Angelino T., Ilse Jongerius, Erik Heezius, et al.. (2020). Pre-existing antibody-mediated adverse effects prevent the clinical development of a bacterial anti-inflammatory protein. Disease Models & Mechanisms. 13(9). 1 indexed citations
12.
Wandel, Michal P., Bae-Hoon Kim, Eui‐Soon Park, et al.. (2020). Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms. Nature Immunology. 21(8). 880–891. 198 indexed citations
13.
Jamilloux, Yvan, et al.. (2018). A proximity-dependent biotinylation (BioID) approach flags the p62/sequestosome-1 protein as a caspase-1 substrate. Journal of Biological Chemistry. 293(32). 12563–12575. 19 indexed citations
14.
Fauteux‐Daniel, Sébastien, Sébastien Viel, Laurie Besson, et al.. (2018). Deletion of Inflammasome Components Is Not Sufficient To Prevent Fatal Inflammation in Models of Familial Hemophagocytic Lymphohistiocytosis. The Journal of Immunology. 200(11). 3769–3776. 5 indexed citations
15.
Santos, José Carlos, Mathias S. Dick, Brice Lagrange, et al.. (2018). LPS targets host guanylate‐binding proteins to the bacterial outer membrane for non‐canonical inflammasome activation. The EMBO Journal. 37(6). 181 indexed citations
16.
Lugrin, Jérôme, Yvan Jamilloux, Aubry Tardivel, et al.. (2016). AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity. Proceedings of the National Academy of Sciences. 113(32). E4671–80. 115 indexed citations
17.
Zannetti, Claudia, Guillaume Roblot, Emily Charrier, et al.. (2016). Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and Pathogens. The Journal of Immunology. 197(1). 356–367. 56 indexed citations
18.
Daussy, Cécile, Fabrice Faure, Katia Mayol, et al.. (2014). T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. The Journal of Experimental Medicine. 211(3). 563–577. 439 indexed citations
19.
Boucrot, Emmanuel, Thomas Henry, Jean‐Paul Borg, Jean‐Pierre Gorvel, & Stéphane Méresse. (2005). The Intracellular Fate of Salmonella Depends on the Recruitment of Kinesin. Science. 308(5725). 1174–1178. 193 indexed citations
20.
Henry, Thomas, et al.. (1996). Methods of interplanting gaps in existing hawthorn (Crataegus monogyna Jacq.) hedges. Aspects of applied biology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026